Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Résumé du profil de sécurité
Les effets indésirables les plus fréquemment rapportés au cours du traitement sont la somnolence, les vertiges, les maux de tête, les palpitations, des bouffées de chaleur, des douleurs abdominales, des nausées, un gonflement de la cheville, un œdème et la fatigue.
Liste tabulée des effets indésirables
Les effets indésirables suivants ont été observés et rapportés au cours du traitement par l'amlodipine aux fréquences suivantes: très fréquent (≥1 / 10); commun (≥1 / 100 à <1/10); peu fréquent (≥ 1/1 000 à <1/100); rare (≥ 1/10 000 à <1/1 000); très rare (<1/10 000).
Au sein de chaque groupe de fréquence, les effets indésirables sont présentés par ordre de gravité décroissante:
System organ class |
Frequency |
Adverse reactions |
Blood and lymphatic system disorders |
Very rare |
Leukocytopenia, thrombocytopenia |
Immune system disorders |
Very rare |
Allergic reactions |
Metabolism and nutrition disorders |
Very rare |
Hyperglycaemia |
Psychiatric disorders |
Uncommon |
Depression, mood changes (including anxiety), insomnia |
Rare |
Confusion |
|
Nervous system disorders |
Common |
Somnolence, dizziness, headache (especially at the beginning of the treatment) |
Uncommon |
Tremor, dysgeusia, syncope, hypoaesthesia, paraesthesia |
|
Very rare |
Hypertonia, peripheral neuropathy |
|
Eye disorders |
Common |
Visual disturbance (including diplopia) |
Ear and labyrinth disorders |
Uncommon |
Tinnitus |
Cardiac disorders |
Common |
Palpitations |
Uncommon |
Arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation) |
|
Very rare |
Myocardial infarction |
|
Vascular disorders |
Common |
Flushing |
Uncommon |
Hypotension |
|
Very rare |
Vasculitis |
|
Respiratory, thoracic and mediastinal disorders |
Common |
Dyspnoea |
Uncommon |
Cough, rhinitis |
|
Gastrointestinal disorders |
Common |
Abdominal pain, nausea, dyspepsia, altered bowel habits (including diarrhoea and constipation) |
Uncommon |
Vomiting, dry mouth |
|
Very rare |
Pancreatitis, gastritis, gingival hyperplasia |
|
Hepatobiliary disorders |
Very rare |
Hepatitis, jaundice, hepatic enzyme increased* |
Skin and subcutaneous tissue disorders |
Uncommon |
Alopecia, purpura, skin discolouration, hyperhidrosis, pruritus, rash, exanthema, urticaria |
Very rare |
Angioedema, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity |
|
Unknown |
Toxic Epidermal Necrolysis |
|
Musculoskeletal and connective tissue disorders |
Common |
Ankle swelling, muscle cramps |
Uncommon |
Arthralgia, myalgia, back pain |
|
Renal and urinary disorders |
Uncommon |
Micturition disorder, nocturia, increased urinary frequency |
Reproductive system and breast disorders |
Uncommon |
Impotence, gynaecomastia |
General disorders and administration site conditions |
Very common |
Oedema |
Common |
Fatigue, asthenia |
|
Uncommon |
Chest pain, pain, malaise |
|
Investigations |
Uncommon |
Weight increased, weight decreased |
* principalement compatible avec la cholestase
Des cas exceptionnels de syndrome extrapyramidal ont été rapportés.
Déclaration des effets indésirables suspectés
La déclaration des effets indésirables suspectés après autorisation du médicament est importante. Il permet une surveillance continue du rapport bénéfice / risque du médicament. Les professionnels de la santé sont priés de signaler tout effet indésirable suspecté via le programme de la carte jaune à l'adresse www.mhra.gov.uk/yellowcard ou de rechercher la carte MHRA dans la boutique Google Play ou Apple App Store.
Groupes de Produits : Médicaments finis > Médicaments cardiovasculaires et urinaires
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.